Short Interest in MDxHealth SA (NASDAQ:MDXH) Rises By 35.0%

MDxHealth SA (NASDAQ:MDXH) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 33,200 shares, an increase of 35.0% from the December 15th total of 24,600 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily volume of 125,900 shares, the days-to-cover ratio is currently 0.3 days.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Lake Street Capital began coverage on shares of MDxHealth in a report on Thursday, October 31st. They issued a “buy” rating and a $7.00 target price for the company. Piper Sandler reduced their price target on shares of MDxHealth from $8.00 to $6.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th.

MDxHealth Stock Down 0.5 %

MDXH traded down $0.01 during trading on Thursday, hitting $1.99. 81,508 shares of the stock were exchanged, compared to its average volume of 197,071. MDxHealth has a 1-year low of $1.55 and a 1-year high of $4.44. The stock has a fifty day moving average price of $2.08 and a two-hundred day moving average price of $2.36. The company has a current ratio of 1.54, a quick ratio of 1.45 and a debt-to-equity ratio of 3.14.

Institutional Trading of MDxHealth

Several institutional investors and hedge funds have recently bought and sold shares of MDXH. Perkins Capital Management Inc. grew its position in MDxHealth by 70.7% during the 3rd quarter. Perkins Capital Management Inc. now owns 747,375 shares of the company’s stock worth $1,555,000 after purchasing an additional 309,500 shares during the last quarter. MVM Partners LLC increased its position in MDxHealth by 3.3% in the 3rd quarter. MVM Partners LLC now owns 4,700,457 shares of the company’s stock valued at $9,706,000 after acquiring an additional 150,000 shares during the period. Maven Securities LTD purchased a new stake in MDxHealth during the 3rd quarter valued at approximately $208,000. Finally, OneDigital Investment Advisors LLC raised its stake in MDxHealth by 15.3% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 57,726 shares of the company’s stock valued at $120,000 after acquiring an additional 7,656 shares during the last quarter.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.